According to previously published data, IL-1β was not always increased in severe COVID-19 cases [25,27], but was significantly lower in asymptomatic cases than in symptomatic patients, suggesting IL-1β levels may be predictors of clinical symptoms [28]. Here, IL1B is linked to COVID-19.